AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

计划入组 35 人 · 首次发布于 2006 年 5 月 4 日

Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia

计划入组 22 人 · 首次发布于 2004 年 6 月 18 日

Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

计划入组 60 人 · 首次发布于 2005 年 9 月 21 日

Alemtuzumab(Campath, Lemtrada, MabCampath)

Rx

Oncoquest-CLL

anti-CD19 CAR T-cell therapy (Chronic lymphocytic leukemia)

Kineta Chronic Pain LLC

United States

JAPAN ADULT LEUKEMIA STUDY GROUP

Japan

AB&B BIO-TECH-B

FDA Updates Fludarabine Phosphate Labeling for CLL Treatment

FDA Updates Fludarabine Phosphate Labeling for CLL Treatment

FDA Updates Labeling for Sandoz Fludarabine in B-Cell CLL Treatment via Project Renewal